The Disease Forecasting Company.
The world’s most trusted independent health intelligence, cited over 16,000 times in 2022
Analysis & Insights
Pre-emptive Health Economics: How to build population level evidence for events that haven’t happened
Airfinity is bringing together some of the leading experts across the life science space for an exclusive roundtable on the role of forecasting in improving disease outcomes and the strategies needed to reduce disease burden.
Read More →More from Airfinity
Airfinity forecasts the severely obese population with metabolic syndrome in the US to grow 50% by 2030 from 26 million to 39.1 million people.Airfinity Launches an RNA Therapeutics and Vaccine Intelligence ToolA strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8% Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific OceanBreakthrough Treatments Could Relegate RSV Seasons Like 2023 To History BooksFormer Editor of The Economist joins Airfinity as advisor View All →In the News
Science finally figured out how to make effective RSV vaccines. Will seniors care?STAT | May 26, 2023
Bird Flu Detectives Seek Clues to Next Global PandemicBloomberg | May 2, 2023
Will your health plan cover new obesity drugs?Bloomberg | Apr 27, 2023
Disease forecasters are convinced there’s a 27% chance of another COVID-like pandemic within 10 years—but experts believe there’s a silver bulletFortune | Apr 18, 2023
View All →
A pioneer in predictive health intelligence
Understand
What's happening in a given disease area?
Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.
Predict
Identify the true need for a vaccine or a treatment.
Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.
Act
Maximise impact to save lives
Our analytics and probabilistic tools inform key decisions on resource allocation, investment and procurement decisions to maximise impact of a given drug or vaccine and ultimately improve as many lives as possible.
The world's most comprehensive infectious disease solutions.
Airfinity combines proprietary surveillance tools and forecast models with expert analysis for dozens of infectious diseases, including COVID-19, Monkeypox, Influenza and RSV.
OUR PLATFORM:
New science
Market & Production
Policies
Disease & Prevalence
What our users say?
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”
Director General,
IFPMA
“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”
James Fransham, Data Journalist,
The Economist